News
Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...
13h
News-Medical.Net on MSNEvolutionary mutation weakens human immune response to solid tumorsNew research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...
Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...
Anita Turk, MD, discusses abstracts from ASCO 2025 highlight the evolving role of ctDNA in the management of colorectal ...
Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.
Colon cancer, also known as colorectal cancer, is a type of cancer that develops in the colon or rectum, the last part of the large intestine. It often starts as small, noncancerous clumps of cells ...
Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...
Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...
Researchers have developed a bioengineered hydrogel platform capable of preserving patient-derived tumor tissues for longer ...
2h
AZoLifeSciences on MSNSmall Genetic Change in Humans Weakens Immune Attack on Solid TumorsNew research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...
Tumors shrank more with the addition of acoustic cluster therapy to chemotherapy in colorectal liver metastases in the phase 1 ACTIVATE trial. As a Lynch syndrome previvor, I feel deep gratitude to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results